Program

Thursday, August 25, 2022
09.00
Conference Opening
09.15
Welcome Message
10.00
Prof. Tom Grossmann, Vrije Universiteit Amsterdam, NL
«Peptidomimetic inhibitors of Wnt signaling that directly target β-catenin»
10.30
Prof. Hiro Suga, University of Tokyo, JP
«The next generation RaPID system»
11.30
Coffee Break
12.00
Dr. Dominik Sarma, Belyntic, DEU
«Developing peptide drugs faster with the Peptide Easy Clean (PEC) technology»
12.30
Assistant Prof. Anne Conibear, TU Wien, AUT
«Decorated venom: Sulfation and amidation of alpha-conotoxins»
13.00
Lunch Break
14.30

Prof. Beatriz Garcia De la Torre,  University of KwaZulu-Natal, ZAF 
Dr. John Lopez, Novartis, Basel
«Beyond the application of RI as PAT in solid-phase synthesis»

15.00
Dr. Samuele Cazzamalli, Philochem, CH
«Small Molecule Therapeutics as an alternative to Peptide Therapeutics: a clean strategy to delivery bioactive payloads to tumors»
15.30
Coffee Break
16.00

Prof. Ali Azhdarinia, University of Texas, US
«Fluorescent peptide conjugates for intraoperative imaging»

16.30

Prof. Gaurav Bhardwaj, University of Washington, US
«Computational peptide design for target therapeutics»

17.00
Poster Session & Apéro
Friday, August 26, 2022
10.00

Dr. Paul Beswick, Bicycle Therapeutics, UK
«Bicycles® (bi-cyclic peptides) as novel therapeutics to treat antimicrobial infection»

10.30

Prof. Ashraf Brik, Technion-Israel Institute of Technology, ISR
«Modulating the Ubiquitin System with Cyclic Peptides: Chemistry and Biology»

11.00
Coffee Break
11.30

Prof. Frank Kirchhoff, University of Ulm, DEU
«Peptidic fusion inhibitors for SARS Cov 2»

12.00

Dr. Martin Bossart, Sanofi, DEU
«Design of SAR441255, a potent unimolecular peptidic triple GLP-1/GIP/GCG receptor agonist and its effects on weight loss and glycemic control»

12.30
Lunch Break
14.00

Dr. Søren Østergaard, Novo Nordisk, DNK
«Designing potent and selective Y2 agonists»

14.30

Prof. William D. Lubell, University of Montreal, CAN
«Inflammation modulation by peptide conformation demarcation»

15.00
Coffee Break
15.30

Dr. Dana Ault-Riche, Maastricht University, NL
«Non-immunogenic synthetic proteins composed of D-amino acids potently inhibit tumor growth»

16.00

Dr. Rami Hannoush, US Ventures, Mubadala Capital, San Francisco, US
«Engineered peptide agonists for cellular reprogramming and tissue regeneration»

16.40
Closing remarks